Molecular Partners AG’s MOLN share price has surged by 9.28%, which has investors questioning if this is right time to sell.

Update on IND-enabling data for MP0712, a Radio-DARPin targeting DLL3 and labeled with 212Pb, co-developed with Orano Med; entering FIH studies ...

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 25, 2025 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a ...

Increasing cancer prevalence, including prostate cancer and neuroendocrine tumors, advances in nuclear medicine in the field ...

Medical oncology is a type of medicine that focuses on the diagnosis, treatment, and prevention of cancer. A medical oncologist’s job is to take care of cancer patients by using things like ...

Experts at the 2025 Clinical Trial Supply New England conference will discuss strategies for optimising clinical supply ...

Thanks to AI, we’re in the midst of an unprecedented technology boom. The medical devices industry hasn’t been left out of it. Among the 10 Most Innovative Companies in the medical device ...

For centuries, women faced seemingly insurmountable barriers to entering medicine and science, and were relegated to roles as caregivers rather than recognized as physicians and surgeons.

Those moves have strained ties with Niger's former imperial master France, with the junta locked in a standoff with the Paris-based Orano nuclear group over its mining presence in the country.

Source: Orano In the health sector, both countries signed a bilateral declaration of understanding on healthcare cooperation during the first Uzbekistan-France Medical Forum in Paris. The agreement ...

French multinational nuclear fuel company Orano and Uzbekistan’s Navoiyuran have signed an agreement to accelerate the industrial development of the South Djengeldi uranium deposit, further expanding ...